We apologise that The Focal Therapy Clinic’s site was experiencing some technical difficulties at the start of the week – if any visitors filled out a contact form and have not heard back from us please do get in touch again and we will contact you very shortly.

AUA 2019: Who Should We Consider for Focal Therapy & How?

This article on the URO Today website covers the SUO session at the AUA 2019 meeting where Dr. Art Rastinehad discusses the selection of patients for Focal Therapy for their prostate cancer.

It highlights how focal therapy evolved from the over diagnosis and over the treatment of prostate cancer in relation to treatment’s side effects, primarily sexual and urinary in nature.

Particular note should be paid to the diagram highlighting the various paradigms in relation to the risk associated with the cancer stage.

The main takeaways for clinicians were that patients eligible for focal therapy should have biopsy-confirmed imaging, biomarkers and MR imaging should be used with targeted biopsy in conjunction with the standard biopsy when evaluating patients and patients should have a biopsy to confirm ablation by 1 year post-treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get In Touch

As a group of consultants we are passionate about prostate cancer sufferers knowing about all of their treatment options.

We know that settling on the right treatment is a big decision for you. If you would like to speak to one of our friendly and knowledgeable patient advocates about your diagnosis and the HIFU Focal Therapy treatment option then please do not hesitate to get in touch today.

All enquiries to The Focal Therapy Clinic are confidential, and we are delighted to offer our advice and support with no obligation.